Abstract & Overview
MicroRNA-146a (miR-146a), known to be widely implicated in the regulation of innate immune signaling and neuroinflammation, is dysregulated in Alzheimer's disease (AD). Both protective and detrimental roles for miR-146a in AD pathogenesis have been reported, indicating context-dependent effects. However, the in vivo role of miR-146a in AD-related cognitive impairment and neuropathology remains incompletely understood. This study aimed to define the functional role of miR-146a in AD pathology and cognitive dysfunction. Expression profiling of microRNAs (miRNAs) was performed in the hippocampus of 5xFAD mice and of human AD brains. To assess functional effects, adeno-associated virus (AAV) vectors were used to modulate miR-146a expression in the hippocampus of 5xFAD mice using pre-miR-146 or miR-146a sponge (146SP) constructs. miR-146a was found significantly upregulated in both 5xFAD mice and human AD hippocampal samples. Inhibition of miR-146a improved cognitive performance, reduced amyloid deposition, and elevated synaptic protein expression. Both miR-146a overexpression and inhibition reduced hippocampal Aβ42 (amyloid-beta 42) levels, suggesting complex regulation of amyloid metabolism. Modulation of miR-146a altered inflammatory signaling and miRNA networks, including differential regulation of IRAK family members and cytokine expression. Correlation analyses revealed a nonlinear relationship between hippocampal miR-146a levels and cognitive performance and identified multiple coordinated associations among miRNAs and inflammatory genes. These findings suggest that miR-146a acts as a context-dependent regulator in AD, influencing amyloid pathology, synaptic integrity, and inflammatory networks. The observed nonlinear relationship between miR-146a expression and cognition suggests that the functional effects of miR-146a may depend on its expression range and regulatory context during AD progression.